Literature DB >> 16630714

Adenocarcinoma of the oesophagus and gastric cardia: male preponderance in association with obesity.

Aoife M Ryan1, Suzanne P Rowley, Anthony P Fitzgerald, Narayanasamy Ravi, John V Reynolds.   

Abstract

Recent evidence links obesity with the rising incidence of oesophageal adenocarcinoma. In Ireland between 1995 and 2004 the incidence of oesophageal adenocarcinoma increased by 38%, and this coincided with a 67% increase in the prevalence of obesity. In this study, a prospective case-control study was undertaken in 760 patients presenting to a tertiary centre between 1994 and 2004 diagnosed with cancer of the oesophagus, gastric cardia or stomach. Data were compared with 893 healthy controls. Multivariate logistic regression models were used to calculate the odds ratio (OR) of developing either cancer type according to quartiles of body mass index (BMI). Based on pre-illness BMI, 82% of patients who developed adenocarcinoma of the oesophagus were either overweight or obese compared with 59% of the healthy control population (P<0.001). A dose-dependent relationship existed between BMI and oesophageal adenocarcinoma in males. The adjusted odds ratio was 4.3 (95% CI: 2.3-7.9) among males in the highest BMI quartile compared with males in the lowest quartile (P<0.001 for trend). Using common cut-off points for BMI, the OR of adenocarcinoma of the lower oesophagus was 11.3 times higher (95% CI: 3.5-36.4) for individuals with a BMI >30 kg/m2 versus individuals with a BMI <22 kg/m2 (P<0.001 for trend). For adenocarcinoma of the gastric cardia, males in the top quartile of BMI had an OR of 3.5 (95% CI: 1.3-9.4) compared with the lowest quartile (P=0.03 for trend). A significant (P<0.001) inverse relationship between BMI and oesophageal SCC was observed. The odds ratio for adenocarcinoma of the oesophagus, the oesophago-gastric junction and gastric cardia rose significantly with increasing BMI. For tumours of the lower oesophagus, obesity increased the risk 10.9-fold. The increased risk is significant in males only.

Entities:  

Mesh:

Year:  2006        PMID: 16630714     DOI: 10.1016/j.ejca.2005.12.024

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  23 in total

1.  Barrett's esophagus before and after Roux-en-Y gastric bypass for severe obesity.

Authors:  Brandon Andrew; Joshua B Alley; Cristina E Aguilar; Robert D Fanelli
Journal:  Surg Endosc       Date:  2017-08-04       Impact factor: 4.584

2.  The association between obesity factor and esophageal caner.

Authors:  Qi Chen; Hengguo Zhuang; Yanhui Liu
Journal:  J Gastrointest Oncol       Date:  2012-09

Review 3.  The role of obesity in gastrointestinal cancer: evidence and opinion.

Authors:  Claire L Donohoe; Naoimh J O'Farrell; Suzanne L Doyle; John V Reynolds
Journal:  Therap Adv Gastroenterol       Date:  2014-01       Impact factor: 4.409

4.  Gastrointestinal issues in the assessment and management of the obese patient.

Authors:  Zulfiqar Hussain; Eamonn M M Quigley
Journal:  Gastroenterol Hepatol (N Y)       Date:  2007-07

5.  A high body mass index in esophageal cancer patients is not associated with adverse outcomes following esophagectomy.

Authors:  Longsheng Miao; Haiquan Chen; Jiaqing Xiang; Yawei Zhang
Journal:  J Cancer Res Clin Oncol       Date:  2014-11-27       Impact factor: 4.553

6.  Sex-specific exposure prevalence of established risk factors for oesophageal adenocarcinoma.

Authors:  M Rutegård; H Nordenstedt; Y Lu; J Lagergren; P Lagergren
Journal:  Br J Cancer       Date:  2010-08-10       Impact factor: 7.640

7.  IGF2R polymorphisms and risk of esophageal and gastric adenocarcinomas.

Authors:  Cathrine Hoyo; Joellen M Schildkraut; Susan K Murphy; Wong-Ho Chow; Thomas L Vaughan; Harvey Risch; Jeffrey R Marks; Randy L Jirtle; Brian Calingaert; Brian Calingeart; Susan Mayne; Joseph Fraumeni; Marilie D Gammon
Journal:  Int J Cancer       Date:  2009-12-01       Impact factor: 7.396

8.  A prospective study of BMI and risk of oesophageal and gastric adenocarcinoma.

Authors:  Christian C Abnet; Neal D Freedman; Albert R Hollenbeck; Joseph F Fraumeni; Michael Leitzmann; Arthur Schatzkin
Journal:  Eur J Cancer       Date:  2008-01-24       Impact factor: 9.162

Review 9.  Obesity and related risk factors in gastric cardia adenocarcinoma.

Authors:  Sidney Olefson; Steven F Moss
Journal:  Gastric Cancer       Date:  2014-09-11       Impact factor: 7.370

10.  Trends in esophageal cancer and body mass index by race and gender in the state of Michigan.

Authors:  Eric J Kort; Eric Sevensma; Timothy L Fitzgerald
Journal:  BMC Gastroenterol       Date:  2009-06-23       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.